Summary: A milestone neuro-regenerative study has shattered a long-standing medical dogma by proving that “irreversible” damage to the connections between the human brain and spinal cord can be ...
SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical ...
(Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for ...
Relmada Therapeutics, Inc. (Nasdaq: RLMD, 'Relmada” or the 'Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today ...
Medicine now rightly recognizes addiction as a neurobiological disorder that may require long-term pharmacologic treatment.
"I wasn’t looking for insight so much as correction. I assumed something in me needed to be trained out of existence.” ...
Cambridge researchers created miniature brain-and-spinal-cord systems in the lab that can send signals and even trigger tiny ...
Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced toda ...
Depression is one of the leading causes of disability in the world: according to WHO, more than 280 million people suffer from the disorder. The disease changes not only the mood, but it rebuilds the ...
Summary: Researchers demonstrated that an experimental, systemic gene therapy can shield the central nervous system from the devastating cognitive decline and structural damage caused by ...
NEW YORK CITY, NY / ACCESS Newswire / May 26, 2026 / Jupiter Neurosciences, Inc. (NASDAQ:JUNS) ("Jupiter" or the "Company"), a clinical-stage biopharmaceutical company focused on central nervous syste ...
On May 13, Lucid Capital initiated coverage of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) with a Buy rating and a $49 price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results